“Harvard is the ideal place to explore the topic of psychedelics from new angles, and to craft a framework for their legal, safe and appropriate impact on society,” Antonio Gracias, president of the Gracias Family Foundation, and the founder, chief executive officer and chief Investment officer of Valor Equity Partners, said in a statement.